Aptevo Therapeutics

Aptevo Therapeutics is a biotech company focused on bringing novel immuno-oncology therapeutics to market. We leverage the innovative ADAPTIR™ and ADAPTIR-FLEX platform technologies to create therapeutic candidates designed to improve outcomes for cancer patients. Our proprietary platforms and therapeutic candidates help position us to enter potential partnering and licensing arrangements, which may include upfront fees, development milestones, royalties and other compensation. At Aptevo Therapeutics, our core values of ownership?and collaboration—combined with a history of innovation, dedication, and development—are positioning Aptevo Therapeutics to develop the science of what’s next in biotechnology.